Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI ...

The assay uses genetic insights for safer chemotherapy treatments to align with updated testing guidelines. “The new kit ...

Imaging CRO Qureight will use its end-to-end imaging technology and services in a clinical trial analysing diffuse cutaneous Systemic Sclerosis (dcSSc). SSc is a complex disease characterised by ...

Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...

A head-to-head dataset from Integrated DNA Technologies shows that Anchored Multiplex PCR (AMP) sustains quality control (QC) and variant recovery where hybrid capture becomes input limited FFPE ...

Organoids, or miniature organ-like structures derived from stem cells, have emerged as transformative tools in biomedical research. Unlike traditional two-dimensional (2D) cell cultures, organoids ...

Sophia Genetics, an AI-driven precision medicine specialist, is collaborating with Synnovis, a UK-based pathology provider, to bring liquid biopsy testing to lung and breast cancer patients across the ...

Creative Biolabs, a biotechnology and life sciences company, is enhancing its integrated immuno-oncology suite, bridging the gap between advanced diagnostics and therapeutic discovery. By synthesizing ...

Sino Biological, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently launched its EliteScience VIP Partnership program, an exclusive premium ...

Arboviruses, particularly Dengue virus (DENV) and Zika virus (ZIKV), represent a massive and escalating global health threat. Transmitted primarily by infected Aedes mosquitoes, Dengue is now endemic ...

Suzhou Ribo Life Science and Ribocure Pharmaceuticals have achieved their third milestone in the research collaboration with Boehringer Ingelheim to discover novel therapies for liver disease, ...

Cellular Intelligence, an AI-native TechBio, has acquired global rights to Novo Nordisk’s clinical-stage cell therapy program for Parkinson’s disease. Cellular Intelligence plans to apply its ...